Pulmonary metastasis remains the leading ca use of death for cancer patients. Opportunities to improve treatment outcomes for patients require new methods to study and view the biology of metastatic progression. Here, we describe an ex vivo pulmonary metastasis assay (PuMA) in which the metastatic progression of GFP-expressing cancer cells, from a single cell to the formation of multicellular colonies, in the mouse lung microenvironment was assessed in real time for up to 21 days. The biological validity of this assay was confirmed by its prediction of the in vivo behavior of a variety of high- and low-metastatic human and mouse cancer cell lines and the discrimination of tumor microenvironments in the lung that were most permissive to metastasis. Using this approach, we provide what we believe to be new insights into the importance of tumor cell interactions with the stromal components of the lung microenvironment. Finally, the translational utility of this assay was demonstrated through its use in the evaluation of therapeutics at discrete time points during metastatic progression. We believe that this assay system is uniquely capable of advancing our understanding of both metastasis biology and therapeutic strategies.
Arnulfo Mendoza, Sung-Hyeok Hong, Tanasa Osborne, Mohammed A. Khan, Kirk Campbell, Joseph Briggs, Ananth Eleswarapu, Lauren Buquo, Ling Ren, Stephen M. Hewitt, El-H. Dakir, Susan Garfield, Renard Walker, Glenn Merlino, Jeffrey E. Green, Kent W. Hunter, Lalage M. Wakefield, Chand Khanna
Title and authors | Publication | Year |
---|---|---|
Pharmacologic inhibition of eIF4A blocks NRF2 synthesis to prevent osteosarcoma metastasis
Michael Lizardo, Christopher Hughes, Yue Zhou Huang, Taras Shyp, Alberto Delaidelli, Hai-Feng Zhang, Sol Shaool, Annalena F. Renner, Farez Burwag, Leanne C. Sayles, Alex Lee, Alejandro Sweet-Cordero, Poul Sorensen |
Clinical cancer research | 2024 |
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis.
Bhat V, Piaseczny M, Goodale D, Patel U, Sadri A, Allan AL |
Clinical & Experimental Metastasis | 2024 |
Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer
Metge BJ, Alsheikh HA, Kammerud SC, Chen D, Das D, Nebane NM, Bostwick JR, Shevde LA, Samant RS |
Cell Death and Disease | 2024 |
State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?
Nuckhir M, Withey D, Cabral S, Harrison H, Clarke RB |
Journal of Mammary Gland Biology and Neoplasia | 2024 |
Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas
Petrescu DI, Yustein JT, Dasgupta A |
Frontiers in Oncology | 2024 |
CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways
Kravtsova-Ivantsiv Y, Goldhirsh G, Ciechanover A |
Proceedings of the National Academy of Sciences of the United States of America | 2024 |
Using the single-cell imaging system and orthotropic footpad injection to establish mouse models for experimental and spontaneous melanoma metastasis
Yu Y, Mendoza A, Merlino G |
2023 | |
Ribosome biosynthesis and Hedgehog activity are cooperative actionable signaling mechanisms in breast cancer following radiotherapy
Metge BJ, Alsheikh HA, Chen D, Elhamamsy AR, Hinshaw DC, Chen BR, Sleckman BP, Samant RS, Shevde LA |
npj Precision Oncology | 2023 |
Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis
Pontius WD, Hong ES, Faber ZJ, Gray J, Peacock CD, Bayles I, Lovrenert K, Chin DH, Gryder BE, Bartels CF, Scacheri PC |
Nature Communications | 2023 |
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs.
Silver KI, Patkar S, Mazcko C, Berger EP, Beck JA, LeBlanc AK |
Veterinary and Comparative Oncology | 2023 |
Systemic Influences of Mammary Cancer on Monocytes in Mice
Robinson A, Burgess M, Webb S, Louwe PA, Ouyang Z, Skola D, Han CZ, Batada NN, González-Huici V, Cassetta L, Glass CK, Jenkins SJ, Pollard JW |
Cancers | 2022 |
Photopharmacological modulation of native CRAC channels using azoboronate photoswitches
Udasin R, Sil A, Zomot E, Cohen HA, Haj J, Engelmayer N, Lev S, Binshtok AM, Shaked Y, Kienzler MA, Palty R |
Proceedings of the National Academy of Sciences | 2022 |
Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors
HA Alsheikh, BJ Metge, HC Pruitt, SC Kammerud, D Chen, S Wei, LA Shevde, RS Samant |
Oncogenesis | 2021 |
Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis
SC Kammerud, BJ Metge, AR Elhamamsy, SE Weeks, HA Alsheikh, AL Mattheyses, LA Shevde, RS Samant |
Laboratory Investigation | 2021 |
T cells promote metastasis by regulating extracellular matrix remodeling following chemotherapy
Haj-Shomaly J, Vorontsova A, Barenholz-Cohen T, Levi-Galibov O, Devarasetty M, Timaner M, Raviv Z, Cooper TJ, Soker S, Hasson P, Weihs D, Scherz-Shouval R, Shaked Y |
Cancer research | 2021 |
NSG Mice Facilitate ex vivo Characterization of Ewing Sarcoma Lung Metastasis Using the PuMA Model
Scopim-Ribeiro R, Lizardo MM, Zhang HF, Dhez AC, Hughes CS, Sorensen PH |
Frontiers in Oncology | 2021 |
Assessing a Novel 3D Assay System for Drug Screening against OS Metastasis
Koons N, Amato N, Sauer S, Warshawsky D, Barkan D, Khanna C |
Pharmaceuticals | 2021 |
Lung-Derived Selectins Enhance Metastatic Behavior of Triple Negative Breast Cancer Cells
Khan SU, Xia Y, Goodale D, Schoettle G, Allan AL |
Biomedicines | 2021 |
Impact of limb amputation and cisplatin chemotherapy on metastatic progression in mouse models of osteosarcoma
Ren L, Huang S, Beck J, LeBlanc AK |
Scientific Reports | 2021 |
Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression
TM Fan, RD Roberts, MM Lizardo |
Frontiers in Oncology | 2020 |
Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
D Shechter, M Harel, A Mukherjee, LM Sagredo, D Loven, E Prinz, S Avraham, V Orian-Rousseau, T Geiger, Y Shaked, H Wolfenson |
Cells | 2020 |
KISS1 in metastatic cancer research and treatment: potential and paradoxes
T Ly, S Harihar, DR Welch |
Cancer and Metastasis Reviews | 2020 |
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma
Ian Bayles, Malgorzata Krajewska, W. Dean Pontius, Alina Saiakhova, James J. Morrow, Cynthia F. Bartels, Jim Lu, Zachary J. Faber, Yuriy Fedorov, Ellen S. Hong, Jaret M. Karnuta, Brian P. Rubin, Drew J. Adams, Rani E. George, Peter Scacheri |
Journal of Clinical Investigation | 2019 |
Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma
M Nomura, N Rainusso, YC Lee, B Dawson, C Coarfa, R Han, JL Larson, R Shuck, L Kurenbekova, JT Yustein |
JNCI Journal of the National Cancer Institute | 2019 |
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
RD Roberts, MM Lizardo, DR Reed, P Hingorani, J Glover, W AllenRhoades, T Fan, C Khanna, EA SweetCordero, T Cash, MW Bishop, M Hegde, AR Sertil, C Koelsche, L Mirabello, D Malkin, PH Sorensen, PS Meltzer, KA Janeway, R Gorlick, BD Crompton |
Cancer | 2019 |
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
JJ Morrow, I Bayles, AP Funnell, TE Miller, A Saiakhova, MM Lizardo, CF Bartels, MY Kapteijn, S Hung, A Mendoza, G Dhillon, DR Chee, JT Myers, F Allen, M Gambarotti, A Righi, A DiFeo, BP Rubin, AY Huang, PS Meltzer, LJ Helman, P Picci, HH Versteeg, JA Stamatoyannopoulos, C Khanna, PC Scacheri |
Nature Medicine | 2018 |
Selective enhancer changes in osteosarcoma lung metastasis
H Kovar |
Nature Medicine | 2018 |
Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1
ED Young, K Strom, AF Tsue, JL Usset, S MacPherson, JT McGuire, DR Welch |
Clinical & Experimental Metastasis | 2018 |
Live Imaging of The Pulmonary Immune Environment
MR Looney, MB Headley |
Cellular Immunology | 2018 |
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Lin TC, Liao YC, Chang WT, Yang CH, Cheng LH, Cheng M, Cheng HC |
Journal of visualized experiments : JoVE | 2018 |
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Lizardo MM, Sorensen PH |
Journal of visualized experiments : JoVE | 2018 |
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
PY Yu, HL Gardner, R Roberts, H Cam, S Hariharan, L Ren, AK LeBlanc, H Xiao, J Lin, DC Guttridge, X Mo, CE Bennett, CC Coss, Y Ling, MA Phelps, P Houghton, CA London, D Heymann |
PloS one | 2017 |
Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
C Rachman-Tzemah, S Zaffryar-Eilot, M Grossman, D Ribero, M Timaner, JM Mäki, J Myllyharju, F Bertolini, D Hershkovitz, I Sagi, P Hasson, Y Shaked |
Cell Reports | 2017 |
Modelling pulmonary microthrombosis coupled to metastasis: distinct effects of thrombogenesis on tumorigenesis
CE Evans, A Palazon, J Sim, PA Tyrakis, A Prodger, X Lu, S Chan, PO Bendahl, M Belting, LV Euler, H Rundqvist, RS Johnson, C Branco |
Biology Open | 2017 |
Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis
L Ren, ES Hong, A Mendoza, S Issaq, CT Hoang, M Lizardo, A LeBlanc, C Khanna |
Oncotarget | 2017 |
Visualization of immediate immune responses to pioneer metastatic cells in the lung
MB Headley, A Bins, A Nip, EW Roberts, MR Looney, A Gerard, MF Krummel |
Nature | 2016 |
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
RE Hurst, A Bastian, L Bailey-Downs, MA Ihnat |
Therapeutic advances in medical oncology | 2016 |
hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
KG Fleten, VA Flørenes, L Prasmickaite, O Hill, J Sykora, GM Mælandsmo, B Engesæter |
Cell Death Discovery | 2016 |
Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression
MM Lizardo, JJ Morrow, TE Miller, ES Hong, L Ren, A Mendoza, CH Halsey, PC Scacheri, LJ Helman, C Khanna |
Neoplasia (New York, N.Y.) | 2016 |
mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo
JJ Morrow, A Mendoza, A Koyen, MM Lizardo, L Ren, TJ Waybright, RJ Hansen, DL Gustafson, M Zhou, TM Fan, PC Scacheri, C Khanna |
Clinical cancer research | 2016 |
Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment.
van den Bijgaart RJ, Kong N, Maynard C, Plaks V |
Journal of visualized experiments : JoVE | 2016 |
CCL9 Induced by TGF Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ
HH Yan, J Jiang, Y Pang, BR Achyut, M Lizardo, X Liang, K Hunter, C Khanna, C Hollander, L Yang |
Cancer research | 2015 |
Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box
H Celik, SH Hong, DD Colon-Lopez, J Han, YS Kont, TZ Minas, M Swift, M Paige, E Glasgow, JA Toretsky, J Bosch, A Uren |
Molecular cancer therapeutics | 2015 |
LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells
Q Wei, ZH Chen, L Wang, T Zhang, L Duan, C Behrens, II Wistuba, JD Minna, B Gao, JH Luo, ZP Liu |
Oncogene | 2015 |
PIK3CAH1047R Accelerates and Enhances KRASG12D-Driven Lung Tumorigenesis
S Green, CL Trejo, M McMahon |
Cancer research | 2015 |
Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level
H Çelik, KP Sajwan, SP Selvanathan, BJ Marsh, AV Pai, YS Kont, J Han, TZ Minas, S Rahim, HV Erkizan, JA Toretsky, A Üren |
Molecular and cellular biology | 2015 |
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
CP Day, G Merlino, T Van Dyke |
Cell | 2015 |
Twenty Years On – What Do We Really Know About Ewing Sarcoma And What Is The Path Forward?
Lawlor ER, Sorensen PH |
Critical Reviews in Oncogenesis | 2015 |
Characterization of the metastatic phenotype of a panel of established osteosarcoma cells
Ren L, Mendoza A, Zhu J, Briggs JW, Halsey C, Hong ES, Burkett SS, Morrow JJ, Lizardo MM, Osborne T, Li SQ, Luu HH, Meltzer P, Khanna C |
Oncotarget | 2015 |
The spatiotemporal cellular dynamics of lung immunity
E Lelkes, MB Headley, EE Thornton, MR Looney, MF Krummel |
Trends in Immunology | 2014 |
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12
A Duquet, A Melotti, S Mishra, M Malerba, C Seth, A Conod, AR Altaba |
EMBO Molecular Medicine | 2014 |
Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
C Khanna, TM Fan, R Gorlick, LJ Helman, ES Kleinerman, PC Adamson, PJ Houghton, WD Tap, DR Welch, PS Steeg, G Merlino, PH Sorensen, P Meltzer, DG Kirsch, KA Janeway, B Weigel, L Randall, SJ Withrow, M Paoloni, R Kaplan, BA Teicher, NL Seibel, M Smith, A Uren, SR Patel, J Trent, SA Savage, L Mirabello, D Reinke, DA Barkaukas, M Krailo, M Bernstein |
Clinical cancer research | 2014 |
SFK/MEK inhibitor combination prevents metastatic outgrowth of dormant tumor cells
Lara H. El Touny, Anthony Vieira, Arnulfo Mendoza, Chand Khanna, Mark Hoenerhoff, Jeffrey E. Green |
Journal of Clinical Investigation | 2013 |
TGF-β signaling in myeloid cells is required for tumor metastasis
Y Pang, SK Gara, BR Achyut, Z Li, HH Yan, CP Day, JM Weiss, G Trinchieri, JC Morris, L Yang |
Cancer Discovery | 2013 |
Epithelial-mesenchymal plasticity in carcinoma metastasis
JH Tsai, J Yang |
Genes & development | 2013 |
Mitochondrial retrograde signaling induces epithelial–mesenchymal transition and generates breast cancer stem cells
M Guha, S Srinivasan, G Ruthel, AK Kashina, RP Carstens, A Mendoza, C Khanna, TV Winkle, NG Avadhani |
Oncogene | 2013 |
BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane
J Alsarraj, F Faraji, TR Geiger, KR Mattaini, M Williams, J Wu, NH Ha, T Merlino, RC Walker, AD Bosley, Z Xiao, T Andresson, D Esposito, N Smithers, D Lugo, R Prinjha, A Day, NP Crawford, K Ozato, K Gardner, KW Hunter |
PloS one | 2013 |
Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis
JH Tsai, JL Donaher, DA Murphy, S Chau, J Yang |
Cancer Cell | 2012 |
The First European Interdisciplinary Ewing Sarcoma Research Summit
H Kovar, J Alonso, P Aman, DN Aryee, J Ban, SA Burchill, S Burdach, ED Alava, O Delattre, U Dirksen, A Fourtouna, S Fulda, LJ Helman, D Herrero-Martin, PC Hogendoorn, U Kontny, ER Lawlor, SL Lessnick, A Llombart-Bosch, M Metzler, R Moriggl, S Niedan, J Potratz, F Redini, GH Richter, LT Riedmann, C Rossig, BW Schäfer, R Schwentner, K Scotlandi, PH Sorensen, MS Staege, F Tirode, J Toretsky, S Ventura, A Eggert, R Ladenstein |
Frontiers in Oncology | 2012 |
Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells.
Hong SH, Ren L, Mendoza A, Eleswarapu A, Khanna C |
Neoplasia (New York, N.Y.) | 2012 |
Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting
GE Davis, AN Stratman, A Sacharidou, W Koh |
International review of cell and molecular biology | 2011 |
Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
G Bulut, SH Hong, K Chen, EM Beauchamp, S Rahim, GW Kosturko, E Glasgow, S Dakshanamurthy, HS Lee, I Daar, JA Toretsky, C Khanna, A Üren |
Oncogene | 2011 |
Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma
L Ren, SH Hong, QR Chen, J Briggs, J Cassavaugh, S Srinivasan, MM Lizardo, A Mendoza, AY Xia, N Avadhani, J Khan, C Khanna |
Cancer research | 2011 |
An in vitro system to study tumor dormancy and the switch to metastatic growth
D Barkan, JE Green |
Journal of visualized experiments : JoVE | 2011 |
MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression
RZ Szmulewitz, R Clark, T Lotan, K Otto, JT Veneris, K Macleod, C Rinker-Schaeffer |
International Journal of Cancer | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |